Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ.

Hepatology. 2012 Jun;55(6):2005-23. doi: 10.1002/hep.25762. No abstract available.

PMID:
22488764
2.

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Association for the Study of Liver Diseases.; American College of Gastroenterology.; American Gastroenterological Association..

Am J Gastroenterol. 2012 Jun;107(6):811-26. doi: 10.1038/ajg.2012.128. No abstract available. Erratum in: Am J Gastroenterol. 2012 Oct;107(10):1598.

PMID:
22641309
3.

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association.; American Association for the Study of Liver Diseases.; American College of Gastroenterologyh..

Gastroenterology. 2012 Jun;142(7):1592-609. doi: 10.1053/j.gastro.2012.04.001. Epub 2012 May 15. No abstract available. Erratum in: Gastroenterology. 2012 Aug;143(2):503.

PMID:
22656328
4.

Non-alcoholic fatty liver disease in children.

Janczyk W, Socha P.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):297-300. doi: 10.1016/j.clinre.2012.03.026. Epub 2012 Apr 21.

PMID:
22521558
5.

Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.

Ismail MH.

Am J Med Sci. 2011 Jun;341(6):485-92. doi: 10.1097/MAJ.0b013e3182018598. Review.

PMID:
21412139
6.

From NAFLD in clinical practice to answers from guidelines.

Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A.

J Hepatol. 2013 Oct;59(4):859-71. doi: 10.1016/j.jhep.2013.05.044. Epub 2013 Jun 7. Review.

7.

Review article: Drug therapy for non-alcoholic fatty liver disease.

Comar KM, Sterling RK.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):207-15. Review.

8.

[Fatty liver and its clinical management in obese adolescents].

González Jiménez E, Schmidt Río-Valle J, Álvarez Ferre J.

Endocrinol Nutr. 2011 Jan;58(1):32-7. doi: 10.1016/j.endonu.2010.10.005. Epub 2011 Jan 7. Review. Spanish.

PMID:
21216209
9.

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

American Gastroenterological Association..

Gastroenterology. 2002 Nov;123(5):1702-4. No abstract available.

PMID:
12404244
10.

[Brief introduction of American practice guideline for the diagnosis and management of non-alcoholic fatty liver disease].

Ding XD, Fan JG.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jun;20(6):430-1. Chinese. No abstract available.

PMID:
23230594
11.

[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis].

Heebøll S, Kazankov K, Poulsen MK, Vilstrup H, Grønbæk H.

Ugeskr Laeger. 2012 Feb 20;174(8):488-90. Danish.

PMID:
22348670
12.

Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.

Bugianesi E, Marzocchi R, Villanova N, Marchesini G.

Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1105-16. Review.

PMID:
15561641
13.

[Pathogenetic treatment of non-alcoholic steatohepatitis: arguments, efficacy, safety].

Bueverov AO, Bogomolov PO, Maevskaia MV.

Ter Arkh. 2007;79(8):88-92. Review. Russian. No abstract available.

PMID:
17926479
14.

KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.

Korean Association for the Study of the Liver (KASL)..

Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28. Review. No abstract available.

15.

[Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis].

Kluwe J, Lohse AW.

Internist (Berl). 2005 Dec;46(12):1324-30. Review. German.

PMID:
16247633
16.

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.

Farrell GC, Chitturi S, Lau GK, Sollano JD; Asia-Pacific Working Party on NAFLD..

J Gastroenterol Hepatol. 2007 Jun;22(6):775-7. No abstract available.

PMID:
17565629
17.

How should we manage patients with non-alcoholic fatty liver disease in 2007?

Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC; Asia-Pacific Working Party on NAFLD..

J Gastroenterol Hepatol. 2007 Jun;22(6):801-8. Review.

PMID:
17565632
18.

Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.

Lebovics E, Rubin J.

Diabetes Metab Res Rev. 2011 Jul;27(5):419-24. doi: 10.1002/dmrr.1198. Review.

PMID:
21425426
19.

[Non-alcoholic fatty liver disease--new view].

Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.

Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish.

PMID:
18702346
20.

[Diagnosis of and therapy for nonalcoholic steatohepatitis].

Onishi S, Saibara T.

Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1876-80. Review. Japanese. No abstract available.

PMID:
17037330

Supplemental Content

Support Center